<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:department>School of Chemistry</gtr:department><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/55CAD61C-23F8-42DD-8068-B51668FA6BFD"><gtr:id>55CAD61C-23F8-42DD-8068-B51668FA6BFD</gtr:id><gtr:firstName>Sumeet</gtr:firstName><gtr:surname>Mahajan</gtr:surname><gtr:orcidId>0000-0001-8923-6666</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FH028757%2F2"><gtr:id>BB0E52B0-0D46-4FFF-853D-9FBDEB2808C3</gtr:id><gtr:title>Plasmon-enhanced spectroscopy and imaging inside cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>EP/H028757/2</gtr:grantReference><gtr:abstractText>Low sensitivity, fast photo-bleaching, photo-degradation and little chemical information are the bane of many biological studies and hamper our understanding of natural phenomena. Through the application of enhanced-spectroscopy techniques such as surface-enhanced fluorescence (SEF) and surface-enhanced (resonant) Raman scattering (SE(R)RS) these bottlenecks can be overcome. The enhancement can be achieved by employing special designer surfaces or nanoparticles of appropriate size, which act as antennae to trap impinging light and funnel it into molecules near the surface. This results in enhanced spectroscopic signals both in fluorescence (SEF) and Raman (SE(R)RS). Moreover, the latter technique has the power to resolve and identify many different molecules in a mixture. In the proposal, key component of cells called microtubules, which play an important role in cell division and, hence, are attractive cancer drug targets are used as the biological subject of investigation. The application of the proposed techniques seeks to find answers to important and enigmatic questions associated with microtubules and in the process prove the benefits of the proposed techniques over conventional spectroscopy &amp;amp; imaging methods. Further, we will study the interaction of a common chemotherapeutic drug with microtubules inside cells. Besides understanding the mechanism of action this in turn could lead to efficient application of drug dosage regimes, less side effects and reduced costs for therapy. Overall, the proposed research will pave the way for application of enhanced-spectroscopic techniques for targeted biological studies and functional imaging and thus establish a new paradigm in biological research.</gtr:abstractText><gtr:potentialImpactText>Apart from academic beneficiaries (contained in separate document) there will be many in the wide public domain that will benefit from the research proposed under this fellowship. In particular, I have strong links with D3 technologies (a subsidiary of Renishaw Plc, a leading Raman equipment supplier) who have commercialized a nanostructured SERS transducer. They I am sure they will benefit from the research and will be keen in using the SEF technology being proposed with their substrates. Biacore Life Sciences (owned by GE) are also engaged in detection technologies and will be interested and also benefit from the research. Pharmaceutical sector will be interested in the research proposed her and in particular, industry engaged in drug discovery and screening could be beneficiaries in the long term. As detailed elsewhere the results can be easily extended to monitor pesticides, weed killers, toxins and even environmental pollutants etc. and therefore could be of benefit to agriculture, public health and hygiene. The methodology proposed here also could be utilized for forensic analysis. Hence, not only the private sector but also the public sector such as DSTL might be interested in harnessing these offshoots of current research. As also mentioned in the case of support, the research proposed here as two complementary impacts that is in advancing current scientific understanding and the other much wider technological significance. The research will be a huge technical advance for bio-imaging and understanding biology and hence have the potential to impact global research. Some of the techniques proposed (such as SEF) are not yet employed much in the UK. Therefore, the project will ultimately result in enhancing the country's competitiveness, and can also lead to wealth creation. The benefits of the research besides increasing creative output across many disciplines, in particular biology. It has the potential to aid drug research such as developing Cancer therapies by increased understanding and new drug testing regimens, faster discovery with low side effects. All of this will enhance health and quality of life of people. In my view with continued funding support many of the benefits can be realized in a 5 to 10 year timescale. Besides sharing and exchanging scientific information through publication in research journals and presentations at conferences we will strive to communicate with prospective industrial partners and collaborators. Intellectual property (IP) generated will handled through the technology transfer office of the University. The University of Cambridge has been carrying out knowledge and technology transfer since the early 1970's and this function is currently performed by Cambridge Enterprise Ltd (CE), wholly owned subsidiary of the University formed in December 2006. Cambridge Enterprise consists of three overlapping business units; Technology Transfer, responsible for working with inventors to evaluate, protect, market and licence intellectual property. Consultancy services; providing support for Cambridge staff and research groups wishing to provide consultancy services to third parties. Seed Funds and Venture Services that work with prospective entrepreneurs to provide access to capital and business expertise. These three business units, together, will provide a comprehensive range of services for identification, protection and exploitation of research results.</gtr:potentialImpactText><gtr:fund><gtr:end>2013-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2012-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>94275</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Astra Zeneca</gtr:description><gtr:id>3AE843CA-8B4A-40B5-A616-5120C0F67686</gtr:id><gtr:impact>Publication:
Jack Taylor, Anna Huefner, Li Li, Jonathan Wingfield and Sumeet Mahajan*, &amp;quot;Nanoparticles and intracellular applications of surface-enhanced Raman spectroscopy, Analyst, 2016, 141, 5037-5055</gtr:impact><gtr:outcomeId>58c6d23c868306.94789253-1</gtr:outcomeId><gtr:partnerContribution>Astra Zeneca are providing specialist knowledge in terms of drugs, targets to test. In addition they have contributed to an EPSRC CASE PhD studentship</gtr:partnerContribution><gtr:piContribution>The methodology developed within the project has led to a collaboration with Astra Zeneca to improve cell-based assays for drug discovery. We have been using and adapting our methodologies for testing drug efficiency and bio-availability inside cells. This can have a huge impact in saving resources before trials go to the animal and clinical testing phase.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1916076</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>ERC Starting Grants</gtr:description><gtr:end>2020-04-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:fundingRef>638258</gtr:fundingRef><gtr:id>52CEF13E-71A0-4271-AC06-AA2AE535DD90</gtr:id><gtr:outcomeId>56dd508c8ca966.57685108</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have developed the use of nano-metallic particles as probes to find out the distribution of biomolecules inside cells. Using this strategy we discovered that the differentiation of biological cells can be tracked optically and reported without sample destruction and use of invasive methods.</gtr:description><gtr:exploitationPathways>The methodology developed can be used in drug discovery where cell based assays are urgently needed to find out the uptake, localisation and concentration of drugs inside them. Thus this can benefit the pharmaceutical industry. Our work also lays the foundation to understand toxicology of metal nanoparticles, which is an increasing concern due to environmental pollution and emerging use of nanoparticles in a variety of products.</gtr:exploitationPathways><gtr:id>7B692A4E-7B57-4156-A821-6D9BE694146E</gtr:id><gtr:outcomeId>56dd533abcb468.27583501</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developed a method to monitor chemicals/biochemicals inside cells using nanoparticles as probes. These probes allow interrogation of cells (live or fixed) by surface-enhanced Raman spectroscopy, a non-destructive, label-free and molecular finger-printing technique.</gtr:description><gtr:id>3A610156-7606-47A0-A815-3768D9183E8B</gtr:id><gtr:impact>The impact has been largely academic. The publication where we published the original methodology has been cited 45 times.</gtr:impact><gtr:outcomeId>58c6d3cb134d99.60262957</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Intracellular SERS</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>077E20F5-7448-4C2F-A3C9-D27776D7340C</gtr:id><gtr:title>Visualizing electromagnetic fields at the nanoscale by single molecule localization.</gtr:title><gtr:parentPublicationTitle>Nano letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34d20680e5eaa338f9ccb43bb5834a6c"><gtr:id>34d20680e5eaa338f9ccb43bb5834a6c</gtr:id><gtr:otherNames>Steuwe C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1530-6984</gtr:issn><gtr:outcomeId>56dd5745a47dc3.32281587</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AE40DFD-2360-4648-94C6-4E16C569D0F1</gtr:id><gtr:title>Gold nanoparticles explore cells: cellular uptake and their use as intracellular probes.</gtr:title><gtr:parentPublicationTitle>Methods (San Diego, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f25d2ce845587d1321c86c0bad9866ec"><gtr:id>f25d2ce845587d1321c86c0bad9866ec</gtr:id><gtr:otherNames>Huefner A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1046-2023</gtr:issn><gtr:outcomeId>56dd53ebbb9bc6.28029323</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1841DC00-A502-4183-87E7-CDBF258E03E9</gtr:id><gtr:title>CARS based label-free assay for assessment of drugs by monitoring lipid droplets in tumour cells.</gtr:title><gtr:parentPublicationTitle>Journal of biophotonics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34d20680e5eaa338f9ccb43bb5834a6c"><gtr:id>34d20680e5eaa338f9ccb43bb5834a6c</gtr:id><gtr:otherNames>Steuwe C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1864-063X</gtr:issn><gtr:outcomeId>5675d9659d8a8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE26C9DB-1364-473F-BC13-337E137D9977</gtr:id><gtr:title>Single Nanoparticle-Based Heteronanojunction as a Plasmon Ruler for Measuring Dielectric Thin Films.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cd97b4a1e149c4f95df16a9cd3b6324"><gtr:id>0cd97b4a1e149c4f95df16a9cd3b6324</gtr:id><gtr:otherNames>Li L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1948-7185</gtr:issn><gtr:outcomeId>5675ea1e134e8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>945323DA-4862-4D1B-B2B7-9DE215270D20</gtr:id><gtr:title>Single nanoparticle SERS probes of ion intercalation in metal-oxide electrodes.</gtr:title><gtr:parentPublicationTitle>Nano letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cd97b4a1e149c4f95df16a9cd3b6324"><gtr:id>0cd97b4a1e149c4f95df16a9cd3b6324</gtr:id><gtr:otherNames>Li L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1530-6984</gtr:issn><gtr:outcomeId>5675d987b777a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01D8F56D-4EE3-4A9B-81A1-497B87D5C631</gtr:id><gtr:title>Intracellular SERS nanoprobes for distinction of different neuronal cell types.</gtr:title><gtr:parentPublicationTitle>Nano letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f25d2ce845587d1321c86c0bad9866ec"><gtr:id>f25d2ce845587d1321c86c0bad9866ec</gtr:id><gtr:otherNames>Huefner A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1530-6984</gtr:issn><gtr:outcomeId>doi_55f93d93d73938d3</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/H028757/2</gtr:identifier></gtr:identifiers><gtr:projectHierarchy><gtr:parents><gtr:parent><gtr:id>9E52EA65-2E04-4F15-98DF-F0BD990BF9C7</gtr:id><gtr:grantRef>EP/H028757/1</gtr:grantRef><gtr:amount>349069.72</gtr:amount><gtr:start>2010-06-01</gtr:start><gtr:end>2012-08-31</gtr:end><gtr:children><gtr:child rel="Transfer"><gtr:id>BB0E52B0-0D46-4FFF-853D-9FBDEB2808C3</gtr:id><gtr:grantRef>EP/H028757/2</gtr:grantRef><gtr:amount>94275.53</gtr:amount><gtr:start>2012-09-01</gtr:start><gtr:end>2013-05-31</gtr:end><gtr:children/></gtr:child></gtr:children></gtr:parent></gtr:parents></gtr:projectHierarchy><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>30</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>64596636-AE88-4F6E-A816-9C4C203E1197</gtr:id><gtr:percentage>30</gtr:percentage><gtr:text>Catalysis &amp; surfaces</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>863FC58A-7217-42EA-B076-663F2D770BB8</gtr:id><gtr:percentage>40</gtr:percentage><gtr:text>Chemical measurement</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>98EA7556-1427-44F9-84F3-BF99B7207302</gtr:id><gtr:percentage>40</gtr:percentage><gtr:text>Analytical Science</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>02567418-12CB-462E-9092-530C6E63B359</gtr:id><gtr:percentage>30</gtr:percentage><gtr:text>Chemical Biology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>0C89BB7D-DCEF-4DCF-84DB-CA53C907AB0E</gtr:id><gtr:percentage>30</gtr:percentage><gtr:text>Surfaces &amp; Interfaces</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>